Asset Management One’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Asset Management One’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,834	Closed	-$55K	–	1346
2016 Q3	$55K	Hold	9,834	–	–	﹤0.01%	1293
2016 Q2	$69K	Hold	9,834	–	–	﹤0.01%	1279
2016 Q1	$65K	Hold	9,834	–	–	﹤0.01%	1302
2015 Q4	$101K	Hold	9,834	–	–	﹤0.01%	1293
2015 Q3	$116K	Buy	+9,834	New	+$109K	﹤0.01%	1285

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Asset Management One's JNP Position: Q4 2016 in Review

Asset Management One sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q4 2016, closing a stake of 9,834 shares — an estimated $55K sold.

Asset Management One first reported a position in JNP in Q3 2015 and held it in 5 quarters. The position peaked at $116K in Q3 2015. 40 funds tracked by Wall St. Rank hold JNP as of Q4 2016.

Asset Management One reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Asset Management One sold 9,834 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2016, an estimated $55K.
Asset Management One first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2015 and held it in 5 quarters.
Asset Management One's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $116K in Q3 2015.
40 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.